Medicare Enrolled

Dr. Jenette Rosenlieb, ARNP

Registered Nurse · Trinity, FL
Low-engagement
9320 STATE ROAD 54, Trinity, FL 34655
7274931808
In practice since 2018 (8 years)
NPI: 1376045757 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Rosenlieb from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rosenlieb? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Rosenlieb

Dr. Jenette Rosenlieb is a registered nurse in Trinity, FL, with 8 years in practice.

Between the years covered by Open Payments, Dr. Rosenlieb received a total of $12,865 from 77 pharmaceutical and/or device companies across 603 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in registered nurse. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Rosenlieb is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 8 years in practice$ $12,865 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$12,865
Total received (2021-2024)
Avg $3,216/year across 4 years
Top 1% in FL for registered nurse
77
Companies
603
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,313 (87.9%)
Other
Charitable contributions, space rental, and other categories
$955 (7.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$597 (4.6%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$4,220
2023
$3,818
2022
$3,065
2021
$1,761

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$1,587
Incyte Corporation
$1,041
Janssen Biotech, Inc.
$901
AstraZeneca Pharmaceuticals LP
$821
Merck Sharp & Dohme LLC
$635
Daiichi Sankyo Inc.
$583
Seagen Inc.
$542
Lilly USA, LLC
$527
PFIZER INC.
$369
GENZYME CORPORATION
$342
Gilead Sciences, Inc.
$318
Bayer Healthcare Pharmaceuticals Inc.
$316
Celgene Corporation
$299
Genentech USA, Inc.
$282
E.R. Squibb & Sons, L.L.C.
$281
Takeda Pharmaceuticals U.S.A., Inc.
$240
Amgen Inc.
$231
EMD Serono, Inc.
$231
JAZZ PHARMACEUTICALS INC.
$213
Regeneron Healthcare Solutions, Inc.
$147
Bayer HealthCare Pharmaceuticals Inc.
$123
Astellas Pharma US Inc
$110
ABBVIE INC.
$100
Blueprint Medicines Corporation
$99
Stemline Therapeutics Inc.
$98
Puma Biotechnology, Inc.
$90
ARRAY BIOPHARMA INC
$86
Eisai Inc.
$84
Kite Pharma, Inc.
$82
Alexion Pharmaceuticals, Inc.
$82
SERVIER PHARMACEUTICALS LLC
$81
EISAI INC.
$80
Adaptive Biotechnologies Corporation
$80
PUMA BIOTECHNOLOGY, INC.
$78
Mirati Therapeutics, Inc.
$73
GlaxoSmithKline, LLC.
$70
Ipsen Biopharmaceuticals, Inc
$67
Myovant Sciences Inc.
$66
Pharmacyclics LLC, An AbbVie Company
$60
TAIHO ONCOLOGY, INC.
$60
Aveo Pharmaceuticals, Inc.
$59
Agios Pharmaceuticals, Inc.
$59
Exelixis Inc.
$55
G1 Therapeutics, Inc.
$54
Pharmacosmos Therapeutics Inc.
$53
AVEO Pharmaceuticals, Inc.
$52
Karyopharm Therapeutics Inc.
$51
SOBI, INC
$51
Medtronic, Inc.
$51
MorphoSys, US Inc.
$50
Sumitomo Pharma America, Inc.
$49
Rigel Pharmaceuticals, Inc.
$48
AbbVie Inc.
$47
CTI BioPharma Corp.
$44
EUSA Pharma (US) LLC
$42
Servier Pharmaceuticals LLC
$41
SUN PHARMACEUTICAL INDUSTRIES INC.
$40
Apellis Pharmaceuticals, Inc.
$36
Kyowa Kirin, Inc.
$36
Genmab U.S., Inc.
$33
GE HealthCare
$30
Pharmacyclics LLC, an AbbVie Company
$26
Taiho Oncology, Inc.
$26
Tempus AI, Inc
$25
Foundation Medicine, Inc.
$23
Dendreon Pharmaceuticals LLC
$22
TerSera Therapeutics LLC
$22
CSL Behring
$20
Sobi, Inc
$20
TOLMAR Pharmaceuticals, Inc.
$19
Global Blood Therapeutics, Inc.
$18
Deciphera Pharmaceuticals Inc.
$18
Dova Pharmaceuticals
$16
PharmaEssentia USA Corporation
$15
Acrotech Biopharma Inc.
$15
Heron Therapeutics, Inc.
$12
Myriad Genetic Laboratories, Inc.
$11
Top 3 companies account for 27.4% of total payments
Associated products mentioned in payments ›
ADCETRIS · ALUNBRIG · AUGTYRO · AYVAKIT · Afstyla · Alecensa · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · CABOMETYX · CALQUENCE · CARVYKTI · CINVANTI · COSELA · CYRAMZA · DARZALEX · DOPTELET · Doptelet · ELIGARD · ELITEK · ELREXFIO · EMPRINT · ENHERTU · EPKINLY · ERLEADA · Empaveli · Enhertu · Epkinly · FOTIVDA · Fabhalta · GAZYVA · IBRANCE · IMBRUVICA · IMFINZI · INLYTA · INQOVI · Itovebi · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kadcyla · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · Nplate · Nubeqa · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · OXBRYTA · Onivyde · Orserdu · PADCEV · PEMAZYRE · PIQRAY · PLUVICTO · POLIVY · POTELIGEO · PROMACTA · PROVENGE · PYRUKYND · Poteligeo · PreciseTumor · QINLOCK · Quzyttir · REBLOZYL · RETEVMO · RYBREVANT · Rezlidhia · SARCLISA · SCEMBLIX · SOMATULINE DEPOT · Stivarga · Sylvant · TABRECTA · TAGRISSO · TASIGNA · TECVAYLI · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VONJO · Venclexta · Vonjo · XALKORI · XPOVIO · XT CDX · XTANDI · Xospata · Xtandi · YONSA · Yescarta · ZEJULA · ZEPZELCA · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (88%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 1% for registered nurse in FL.

Looking for a registered nurse in Trinity?
Compare registered nurses in the Trinity area by procedure volume, costs, and industry payment transparency.
Browse registered nurses nearby

Geographic Context

Registered Nurses within 10 mi
535
Per 100K population
90.9
County median income
$67,384
Nearest hospital
HCA FLORIDA TRINITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Rosenlieb is a registered nurse, and high industry engagement (low-engagement, top 1%).

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Rosenlieb receive payments from pharmaceutical companies?
Yes. Dr. Rosenlieb received a total of $12,865 from 77 companies across 603 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Rosenlieb) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →